Bayesian Outcome-Adaptive Randomization Designs
Publié le
IDDI Free Live Webinar: Bayesian Outcome-Adaptive Randomization Designs: a promise not without peril Learn on the crucial elements of implementing OAR…
Publié le
IDDI Free Live Webinar: Bayesian Outcome-Adaptive Randomization Designs: a promise not without peril Learn on the crucial elements of implementing OAR…
Publié le
Free Webinar on Expansion Cohorts in Early Development of Anticancer Agents In this webinar we reviewed: The recent literature related…
Publié le
The need to consider randomization whenever feasible in expansion cohorts The purpose of IDDI comments on FDA Draft guidance is to…
Publié le
Free Live Webinar: Assessing Treatment Benefit in Immuno-Oncology In this webinar we reviewed key issues related to endpoints in immuno-oncology,…
Publié le
Free Webinar on Biostatistical Challenges of Trials in Rare Diseases VIEW RECORDED WEBINAR CONTENTS: In this webinar: We will start by…
Publié le
A New Statistical Method: Generalized Pairwise Comparisons to Assess Treatment Benefit/Risk IN THIS WEBINAR OUR SPEAKERS DESCRIBED A NEW STATISTICAL METHOD,…
Publié le
Since the early days of clinical cancer research, given the expected direct cytotoxicity of chemotherapy, tumor shrinkage has been used…
Publié le
Clinical Research Consultants Our Clinical Research Consultants provide Clinical, Statistical and Regulatory Expert Services to accelerate the development of your drug, biomarker…
Publié le
IDDI in the Media BIOWIN Newsletter Deux projets de R&D dans les starting-blocks (July 2017): “TREATBEST, est un consortium composé…
Publié le
IDDI organized a webinar on the current use and potential of Health Technology Assessment (HTA) as a component of clinical trials…